Baxter BioSurgery

Baxter BioSurgery is a global leader in the development of advanced surgical solutions, specializing in hemostasis, tissue sealing, and adhesion prevention. As a key division of Baxter International, it offers a robust portfolio of biological and mechanical products, including Tisseel fibrin sealant and Floseal hemostatic matrix. The company focuses on improving clinical outcomes across various surgical disciplines, such as cardiovascular, neurosurgery, and orthopedics. Through strategic acquisitions like Seprafilm and PerClot, Baxter BioSurgery continues to expand its footprint in the biosurgery and regenerative medicine markets. Its products are essential in managing intraoperative bleeding and reducing post-operative complications globally.